The emerging metabolic regulatory nodes include olfactory receptor OR51E2, which is aberrantly expressed in RA adipose tissue, regulates lipolysis through the cAMP-PKA pathway, and is associated with insulin resistance. The gene discussed is OR51E2; the disease is rheumatoid arthritis.